1. “Antimicrobial Effectiveness of Prosidyan FIBERGRAFT® Bone Graft Substitutes.” R. Batish, S. Bondre, C. Bagga. Podium presentation, SFB 2018 Annual Meeting, Atlanta, Georgia, April 11-13, 2018.

  1. “Evaluation of the Nano-Crystalline Hydroxyapatite Forming ability of Novel Bioactive Glass Micro Fiber – Collagen Matrix. S. Bondre, C. Bagga. Podium presentation, SFB 2018 Annual Meeting, Atlanta, Georgia, April 11-13, 2018.

  1. Clinical experiences with FIBERGRAFT bioactive synthetic bone graft substitute, an ultraporous bone graft made from bioactive glass fibers.” Dr Adam Bruggeman. Podium presentation, 2018 Selby Spine Conference, January 31 to February 3, 2018.

  1. “Novel Bioactive Glass Micro Fiber – Collagen Matrix Facilitates Posterolateral Spine Fusion.” WR. Walsh, PhD, Hyun Bae, MD. Innovative Technology Presentations, North American Spine Society 32nd Annual Meeting, Orlando, FL, October 25-28, 2017. Tracking Number: AM17NTABS00019.

  1. Use of FIBERGRAFT BG morsels mixed with BMA in anterior cervical discectomy and fusion at 1, 2, 3 and 4 levels: A retrospective analysis of fusion results. H. Bedi, MD, Podium presentation, The 14th Annual Cabo Meeting: State of Spine Surgery Think Tank, June 15 – 17, 2017 Los Cabos, Mexico.

  1. “Synthetic bioactive bone grafts (Prosidyan).” Dr Adam Bruggeman, Podium presentation, The 14th Annual Cabo Meeting: State of Spine Surgery Think Tank, June 15 – 17, 2017 Los Cabos, Mexico.

  1. “Posterolateral Spine Fusion using Novel Micro and Nanofiber based Bioactive Glass Putty.” WR Walsh, ROliver, C Chistou, T Wang, ER Walsh, V Lovric, M Pelletier, S Bondre. Podium presentation, SMIS 2017 Annual Meeting, Las Vegas, NV, September 14–16, 2017.

  1. Use of FIBERGRAFT® BG Morsels mixed with Local Bone Autograft and BMA in Posterolateral Lumbar Spine Fusion: A Retrospective Analysis of Fusion Results. Babak Barcohana MD, Tooraj T. Gravori MD, Stepan Kasimian MD, Lacey Feldman BS. Podium presentation, SMIS 2017 Annual Meeting, Las Vegas, NV, September 14–16, 2017.

  1. “Posterolateral Fusion in a NZ White Rabbit Model using a Novel BioGlass Fiber Combined with Autograft.” WR Walsh, ROliver, C Chistou, T Wang, ER Walsh, V Lovric, M Pelletier, S Bondre. Poster#390, ORS 2017 Annual Meeting, San Diego, California, March 19-22.

  1. “Antimicrobial effectiveness of Prosidyan Fibergraft® bone graft material against a range of microorganisms.” Luc M. Fortier, Hyun W Bae, Edward H Chung, Lacey A. Bauer. Research Article-Journal of Spine Care (JSC). March 10, 2017

  1. “Use of FIBERGRAFT BG Morsels Mixed with BMA In Anterior Cervical Discectomy And Fusion At 1, 2, 3 And 4 Levels: A Retrospective Analysis Of Fusion Results.” Fortier L, Bauer L and Chung E. Research Article, J Spine Neurosurg Vol: 6 Issue: 3. April 22, 2017.
  2. “Bioactive Glass Cleared for Postero-Lateral Fusion.” Robin Young. Volume 11, Issue 37, November 24, 2015.

  1. “Bioglass is Back– In an Incredible New Form.” Robin Young. Orthopedics This Week. Thu, October 16th, 2014.

  1. “In Vitro Human Umbilical Vein Endothelial Cells Response to Ionic Dissolution Products from Lithium-Containing 45S5 Bioactive Glass.” Haro Durand LA, Vargas GE, Vera-Mesones R, Baldi A, Zago MP, Fanovich MA, Boccaccini AR, Gorustovich A. Materials (Basel). 2017 Jul 3;10(7).

  1. “Influence of 45S5 Bioactive Glass in A Standard Calcium Phosphate Collagen Bone Graft Substitute on the Posterolateral Fusion of Rabbit Spine.” Pugely AJ, Petersen EB, DeVries-Watson N, Fredericks DC. Iowa Orthop J. 2017;37:193-198.

  1. “Development of a novel bioactive glass suitable for osteosarcoma-related bone grafts.”  Yazdi, Alireza Rahimnejad, Lawrence Torkan, Stephen D. Waldman, and Mark R. Towler. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2017.

  1. “A comparative in vivo evaluation of bioactive glasses and bioactive glass-based composites for bone tissue repair.” Bellucci, Devis, Alexandre Anesi, Roberta Salvatori, Luigi Chiarini, and Valeria Cannillo. Materials Science and Engineering: C79 (2017) Pages 286-295.

  1. “Bioactive-glass in Oral and Maxillofacial Surgery,” A.C. Profeta and C. Huppa, Craniomaxillofac Trauma Reconstr. (2016) 9(1):1-14. Doi:10.1055.

  1. “Biodegradable Mesoporous Bioactive Glass Nanospheres for Drug Delivery and Bone Tissue Regeneration,” Wang, X., & Li, W. (2016). Nanotechnology,27(22), 225102.

  1. “Bioglass: 10 Milestones from Concept to Commerce,” Hench, L. L. (2016). Journal of Non-Crystalline Solids, 432, 2-8. doi:10.1016/j.jnoncrysol.2014.12.038

  1. “Functionalized Mesoporous Bioactive Glass Scaffolds for Enhanced Bone Tissue Regeneration,” Deliang, Z., & Xinquan, J., Front. Bioeng. Biotechnol. Frontiers in Bioengineering and Biotechnology, (2016) doi:10.3389/conf.fbioe.2016.01.02648

  1. “Injectable Bioative Glass in the Restoration of Oral Bone Defect,” C.B. Han, S.C An. Eur Rev Med Pharmacol Sci. (2016) 1665-8

  1. “Investigation of Bioactivity, Biocompatibility and Thermal Behavior of Sol–gel Silica Glass Containing a High PEG Percentage,” Catauro, M., Renella, R., Papale, F., & Ciprioti, S. V., (2016) Materials Science and Engineering: C (2016) 61, 51-55.

  1. “Mechanical Behaviour of Bioactive Glass Granules and Morselized Cancellous Bone Allograft in Load Bearing Defects,” Hulsen, D., Geurts, J., Gestel, N. V., Rietbergen, B. V., & Arts, J., Journal of Biomechanics, (2016). 49(7), 1121-1127.

  1. “Nanoscale Bioactive Glass Activates Osteoclastic Differentiation of RAW 264.7 Cells,” Detsch, R., Rübner, M., Strissel, P. L., Mohn, D., Strasser, E., Stark, W. J., Boccaccini, A. R., Nanomedicine, 11(9) (2016) 1093-1105.

  1. “Phosphate Glass Fibre Scaffolds: Tailoring of the Properties and Enhancement of the Bioactivity Through Mesoporous Glass Particles,” G. Novajra, N. G. Boetti, J. Lousteau, S. Fiorilli, D. Milanese and C. Vitale-Brovarone, Materials Science and Engineering, C (2016) 570-580.

  1. “Three-Dimensional Polymer Coated 45S5-type Bioactive Glass Scaffolds Seeded With Human Mesenchymal Stem Cells Show Bone Formation in Vivo,” Westhauser, F., Weis, C., Prokscha, M., Bittrich, L. A., Li, W., Xiao, K., Moghaddam, A., J Mater Sci: Mater Med Journal of Materials Science: Materials in Medicine, 27(7) (2016) doi:10.1007/s10856-016-5732-3

  1. “Enhanced Osteoprogenitor Elongated Collagen Fiber Matrix Formation by Bioactive Glass Ionic Silicon Dependent on Sp7 (Osterix) Transcription,” Varanasi, V. G., Odatsu, T., Bishop, T., Chang, J., Owyoung, J., & Loomer, P. M., Journal of Biomedical Materials Research Part A J. Biomed. Mater. Res.(2016).

  1. “A Glass Fiber-Reinforced Composite – Bioactive Glass Cranioplasty Implant: A Case Study of an Early Development Stage Implant Removed Due to a Late Infection,” Posti, J. P., Piitulainen, J. M., Hupa, L., Fagerlund, S., Frantzén, J., Aitasalo, K. M., Vallittu, P. K. (2016) Journal of the Mechanical Behavior of Biomedical Materials, 55, 191-200.

  1. “A Biomimetic Extracellular Matrix Composed of Mesoporous Bioactive Glass as a Bone Graft Material,” Hsu, F., Weng, R., Lin, H., Lin, Y., Lu, M., Yu, J., & Hsu, H. (2015). Microporous and Mesoporous Materials, 212, 56-65.

  1. “Bioactive Borate Glass Promotes the Repair of Radius Segmental Bone Defects by Enhancing the Osteogenic Differentiation of BMSCs,” Zhang, J., Guan, J., Zhang, C., Wang, H., Huang, W., Guo, S., Wang, Y., Biomed. Mater. Biomedical Materials, 10(6), (2015) 065011.

  1. “Bioactive Glass for Large Bone Repair,” W. Jia, G.Y. Lau, W. Huang, C. Zhang, A.P. Tomisa and Q. Fu, Adv Healthc Mater 4(18):2842-8 (2015).

  1. “Bioactive Dlass for Long Bone Infection: A Systematic Review,” Aurégan, J., & Bégué, T, Injury, 46. (2015).

  1. “Bioactive Glass in Cavitary Bone Defects: A Comparative Experimental Study in Rabbits,” Camargo, A. F., Baptista, A. M., Natalino, R., & Camargo, O. P. Acta Ortop. Bras. Acta Ortopédica Brasileira, 23(4), 202-207. (2015).

  1. “Bioactive-glass in Periodontal Surgery and Implant Dentistry,” Profeta, A. C., & Prucher, G. M. Mater. J. Dental Materials Journal,34(5), 559-571. (2015).

  1. “Bioactive Glasses Beyond Bone and Teeth: Emerging Applications in Contact with Soft Tissues,” Miguez-Pacheco, V., Hench, L. L., & Boccaccini, A. R. (2015). Acta Biomaterialia, 13, 1-15.


  1. “Bioactive Glasses: Frontiers and Challenges,” Hench, L. L., & Jones, J. R., Bioeng. Biotechnol. Frontiers in Bioengineering and Biotechnology,3. (2015)

  1. “Bioactive Glasses – Structure and Properties,” D.S. Brauer, Angew Chem Int Ed Engl (2015). 54(14):4160-81.

  1. “Biological Impact of Bioactive Glasses and Their Dissolution Products,” A. Hoppe and A.R. Boccaiccini, Front Oral Biol (2015).

  1. “Characterization and Biocompatibility of a Fibrous Glassy Scaffold,” Gabbai-Armelin, P. R., Souza, M. T., Kido, H. W., Tim, C. R., Bossini, P. S., Fernandes, K. R., Renno, A. C. (2015). J Tissue Eng Regen Med Journal of Tissue Engineering and Regenerative Medicine.

  1. “Effect of a New Bioactive Fibrous Glassy Scaffold on Bone Repair,” Gabbai-Armelin, P. R., Souza, M. T., Kido, H. W., Tim, C. R., Bossini, P. S., Magri, A. M., Renno, A. C. (2015). J Mater Sci: Mater Med Journal of Materials Science: Materials in Medicine, 26(5).

  1. “Effect of Size of Bioactive Glass Nanoparticles on Mesenchymal Stem Cell Proliferation for Dental and Orthopedic Applications,” Ajita, J., Saravanan, S., & Selvamurugan, N. (2015). Materials Science and Engineering: C, 53, 142-149.

  1. “Electrophoretic Deposition of Mesoporous Bioactive Glass on Glass–Ceramic Foam Scaffolds for Bone Tissue Engineering,” Fiorilli, S., Baino, F., Cauda, V., Crepaldi, M., Vitale-Brovarone, C., Demarchi, D., & Onida, B. (2015) J Mater Sci: Mater Med Journal of Materials Science: Materials in Medicine, 26(1).

  1. “Emerging Developments in the Use of Bioactive Glass for Reconstruction of Craniofacial Bone,” Profeta, A. (2015). British Journal of Oral and Maxillofacial Surgery, 53(8), 760-762.

  1. “Fiber Glass–Bioactive Glass Composite for Bone Replacing and Bone Anchoring Implants,” Vallittu, P. K., Närhi, T. O., & Hupa, L. (2015). Dental Materials, 31(4), 371-381.

  1. “Improved Dimensional Stability with Bioactive Glass Fibre Skeleton in Poly(lactide-co-glycolide) Porous Scaffolds for Tissue Engineering,” Haaparanta, A., Uppstu, P., Hannula, M., Ellä, V., Rosling, A., & Kellomäki, M. (2015). Materials Science and Engineering: C, 56, 457-466.

  1. “Silicon: The Evolution of its Use in Biomaterials,” Henstock, J., Canham, L., & Anderson, S. (2015). Acta Biomaterialia, 11, 17-26.

  1. “The Future of Bioactive Ceramics,” Hench, L. L. (2015). J Mater Sci: Mater Med Journal of Materials Science: Materials in Medicine, 26(2).

  1. “A Review of the Effect of Various Ions on the Properties and the Clinical Applications of Novel Bioactive Glasses in Medicine and Dentistry,” Ali, S., Farooq, I., & Iqbal, K. (2014). The Saudi Dental Journal, 26(1), 1-5.

  1. “Bioactive Glasses with Improved Processing. Part 1. Thermal Properties, Ion Release and Apatite Formation,” Groh, D., Döhler, F., & Brauer, D. S. (2014).Acta Biomaterialia, 10(10), 4465-4473. doi:10.1016/j.actbio.2014.05.019

  1. “Cotton-Wool-Like Bioactive Glasses for Bone Regeneration,” Poologasundarampillai, G., Wang, D., Li, S., Nakamura, J., Bradley, R., Lee, P., Jones, J. (2014). Acta Biomaterialia, 10(8), 3733-3746.

  1. “Effect of Implant Design and Bioactive Glass Coating on Biomechanical Properties of Fiber-Reinforced Composite Implants,” Ballo, A. M., Akca, E., Ozen, T., Moritz, N., Lassila, L., Vallittu, P., & Närhi, T. (2014). Eur J Oral Sci European Journal of Oral Sciences, 122(4), 303-309.

  1. “Evaluation of the Bone Regeneration Potential of Bioactive Glass in Implant Site Development Surgeries: A Systematic Review of the Literature,” Ioannou, A. L., Kotsakis, G. A., Kumar, T., Hinrichs, J. E., & Romanos, G. (2014). Clin Oral Invest Clinical Oral Investigations,19(2), 181-191.

  1. “Healing of Critical-size Segmental Defects in Rat Femora Using Strong Porous Bioactive Glass Scaffolds,” Bi, L., Zobell, B., Liu, X., Rahaman, M. N., & Bonewald, L. F. (2014). Materials Science and Engineering: C,42, 816-824.

  1. “Odontogenic Differentiation and Dentin Formation of Dental Pulp Cells Under Nanobioactive Glass Induction,” Wang, S., Gao, X., Gong, W., Zhang, Z., Chen, X., & Dong, Y. (2014). Acta Biomaterialia,10(6), 2792-2803.

  1. “Review: Emerging Developments in the Use of Bioactive Glasses for Treating Infected Prosthetic Joints,” Rahaman, M. N., Bal, B. S., & Huang, W. (2014). Materials Science and Engineering: C, 41, 224-231.

  1. “Review of bioactive glass: from Hench to hybrids”, Jones JR, Acta Biomater. 2013 Jan;9(1):4457-86. doi: 10.1016/j.actbio.2012.08.023. Epub 2012 Aug 21.

  1. “A new synthesis route to high surface area sol gel bioactive glass through alcohol washing: a preliminary study”, Mukundan LM, Nirmal R, Vaikkath D, Nair PD. Biomatter. 2013 Apr-Jun;3(2). e24288-1 to e24288-10.

  1. “Chronology of Bioactive Glass Development and Clinical Applications”, Larry L. Hench, New Journal of Glass and Ceramics, 2013, 3, 67-73

  1. “Bioactive glass in tissue engineering”, Mohamed N. Rahaman, Delbert E. Day, B. Sonny Bal, Qiang Fu, Steven B. Jung, Lynda F. Bonewald, and Antoni P. Tomsia, Acta Biomater. 2011 June ; 7(6): 2355–2373.

  1. “Development and Applications of Varieties of Bioactive Glass Compositions in Dental Surgery, Third Generation Tissue Engineering, Orthopaedic Surgery and as Drug Delivery System”, Samit Kumar Nandi, Biswanath Kundu and Someswar Datta, Chapter 4, Biomaterials Applications for Nanomedicine. Edited by Rosario Pignatello, ISBN 978-953-307-661-4, 470 pages, Publisher: InTech, Chapters published November 16, 2011 under CC BY 3.0 license.

  1. “Bioactive Glass and Glass-Ceramic Scaffolds for Bone Tissue Engineering”, Lutz-Christian Gerhardt and Aldo R. Boccaccini, Materials 2010, 3, 3867-3910.

  1. “Enhanced osteocalcin expression by osteoblast-like cells (MC3T3-E1) exposed to bioactive coating glass (SiO2-CaO-P2O5-MgO-K2O-Na2O system) ions”, Varanasi VG1, Saiz E, Loomer PM, Ancheta B, Uritani N, Ho SP, Tomsia AP, Marshall SJ, Marshall GW, Acta Biomater. 2009 Nov;5(9):3536-47.

  1. “Genetic design of bioactive glass” Larry L. Hench, Journal of the European Ceramic Society, 29 (2009) 1257–1265.

  1. “Bioactive glass as a bone substitute for spinal fusion in adolescent idiopathic scoliosis; a comparative study with iliac crest autograph”, Ilharreborde B, Morel E, Fitoussi F, et al.  J Pediatr Orthop 2008:28;347-351.


  1. “Growth and differentiation of osteoblastic cells on 13-93 bioactive glass fibers and scaffolds” Brown RF1, Day DE, Day TE, Jung S, Rahaman MN, Fu Q, Acta Biomater. 2008 Mar;4(2):387-96.


  1. “Antimicrobial effect of nanometric bioactive glass 45S5”, Waltimo T, Brunner TJ, Vollenweider M, Stark WJ, Zehnder M. J Dent Res. 2007 Aug;86(8):754-7.

  1. “Bioactive Glass Scaffolds for Bone Regeneration”, Julian R. Jones, Eileen Gentleman and Julia Polak, Elements, Vol. 3, PP 393-399, December 2007.


  1. “Optimising bioactive glass scaffolds for bone tissue engineering”, Julian R. Jones, Lisa M. Ehrenfried, Larry L. Hench, Biomaterials 27 (2006) 964–973


  1. “Bioglass®: A short history and bibliography”, L. L. Hench, June W. Hench and D. C. Greenspan, J. Aust. Ceram. Soc., [40], 1, 2004, pages 1-42.


  1. “Bioactive evaluation of 45S5 bioactive glass fibers and preliminary study of human osteoblast attachment”, Clupper DC, Gough JE, Embanga PM, Notingher I, Hench LL, Hall MM. J Mater Sci Mater Med. 2004 Jul;15(7):803-8.

  1. “Osteoblast attachment and mineralized nodule formation on rough and smooth 45S5 bioactive glass monoliths”, Gough JE, Notingher I, Hench LL, J Biomed Mater Res A. 2004 Mar 15;68(4):640-50.

  1. “Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 12-month clinical and radiological study”, R Mengel, M Soffner, L Flores-de-Jacoby, J Periodontol, 74;6:899-908, June (2003).


  1. “Indirect cytotoxicity evaluation of soluble silica, calcium and phosphate ions”, J. Selvakumaran, P.Saravanapavan and L.L. Hench, Bioceramics 16 International Symposium on Ceramics in Medicine (2003).

  1. “Bioactive Materials for Tissue Engineering Scaffolds”, Larry L Hench, Julian R Jones, Pilar Sepulveda, Chapter 1. Future Strategies for Tissue and Organ Replacement, Edited by: Julia M Polak, Larry L Hench, P Kemp , 448pp, May 2002. ISBN: 978-1-86094-964-7.

  1. “Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution”, Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM, J Biomed Mater Res. 2001 May;55(2):151-7.

  1. “Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation In vitro: implications and applications for bone tissue engineering”, Xynos ID, Hukkanen MV, Batten JJ, Buttery LD, Hench LL, Polak JM, Calcif Tissue Int. 2000 Oct;67(4):321-9.

  1. “A bioactive glass particulate in the treatment of molar furcation invasion”, CR Anderegg, DC Alexander, M Freidman, (1999)J Periodontol, 70; 4:384-7.

  1. “Histologic Observations of Periodontal Wound Healing After Treatment with PerioGlasÔ in Non-Human Primates,” S. Karatzas, A. Zavras, D. Greenspan, S. Amar, (1999) Intl J Perio Res Den, 19 (5).

  1. “Clinical evaluation of bioactive glass in the treatment of periodontal osseous defects in humans”, TB Lovelace, JT Mellonig, RM Meffert, AA Jones, PV Nummikoski, DL Cochran, J Periodontol, (1998) 69; 9:1027-35.

  1. “Comparison of BioglassÒ Synthetic Bone Graft Particles and Open Debridement in the Treatment of Human Periodontal Defects”, J. Froum , S.C. Cho, E. Rosenberg, M. Roher, and D. Tarnow, J. Perio; (1998) 69:698-709.

  1. “An evaluation of bioactive ceramic in the treatment of periodontal osseous defects”, SB Low, CJ King, J Krieger, Int J Periodontics Restorative Dent, 17;4:358-67, August (1997).

  1. “Analysis of the chemical transformation of bioactive glass particles after implantation”, E Schepers, L Barbier, A Huygh, P Ducheyne, J Oral Rehabilitation, 24: 171-181, (1997).

  1. “Behavior of Bioactive Glass (S53P4) in Human Frontal Sinus Obliteration”, K Aitasalo, J Suonpaa, M Peltola, A Yli-Urpo, Bioceramics, 10: 429-32, October (1997).

  1. “Clinical use of a bioactive glass particulate in the treatment of human osseous defects”, CA Shapoff, DC Alexander, AE Clark, Compend Contin Educ Dent, 18;4:352-4, April (1997).

  1. “Particulate Bioglass® Compared with Hydroxyapatite as a Bone Graft Substitute,” H. Oonishi, S. Kutrshitani, E. Yasukawa, H. Iwaki, L. L. Hench, J. Wilson, E. Tsuji, and T. Sugihara, Clinical Orthopaedics and Related Research, 334 (1997), 316-325.

  1. “Using 45S5 Bioglass® Cones as Endosseous Ridge Maintenance Implants to Prevent Alveolar Ridge Resorption: A 5-Year Evaluation,” Harold R. Stanley, Matthew B. Hall, Arthur E. Clark, Caleb J. King III, Larry L. Hench, Joseph J. Berte, J. Oral Maxillofac. Implants, 12 (1997), 95-105.

  1. “Ossicular Replacement Prostheses”, K. Lobel, in Clinical Performance of Skeletal Prostheses, Hench and Wislon (eds), Chapman and Hall, Ltd, London, (1996), pp. 214-236.

  1. “Alveolar Ridge Maintenance Implants” H.R.Stanley, A.E.Clark, June Wilson and L.L.Hench. Clinical Performance of Skeletal Prostheses. L.L.Hench and June Wilson, Eds. Chapman and Hall, Publishers,London, England (1995).

  1. “Bioglass® Middle Ear Devices: Ten year Clinical Results” June Wilson, Ellis Douek and Kevin Rust. Bioceramics 8, (1995) June Wilson, L.L.Hench and D. Greenspan, Eds. Elsevier Science, Oxford, England, Publishers.

  1. “Bone Growth into Spaces Between 45S5 Bioglass® Granules,” H. Oonishi, S. Kushitani, E. Yasukawa, H. Kawakami, A. Nakata, S. Koh, L. L. Hench, J. Wilson, E. Tsuji, and T. Sugihara, in Bioceramics 7, Ö. H. Andersson and A. Yli-Urpo, eds., Butterworth-Heinemann Ltd., Oxford, England (1994), 139-144.

  1. “Periodontal Repair Using Perioglas® in NonHuman Primates: Clinical and Histologic Observations”, A.E. Fetner, M.S. Hartigan, S.B.Low, Compendium Contin Educ Dent, 15(7), 932-939, 1994.

  1. “Tissue Response to Bioglass® Endosseous Ridge Maintenance Implants,” June Wilson, A. E. Clark, M. Hall and L. L. Hench, Oral Implantology, XIX[4], (1993), 295-302.

  1. “Bioactive Ceramics for Periodontal Treatment: Comparative Studies.” June Wilson and S.B.Low. Applied Biomaterials, Vol.3, (1992) 123-129.

  1. “Bioactive glass particulate material as a filler for bone lesions”, E Schepers, M de Clercq, P Ducheyne, Journal of Oral Rehabilitation, 18: 439-452, (1991).

  1. “Otologic Applications of Bioglass® Implants,” E. Douek, in Proceedings of IVth International Symposium on Bioceramics in Medicine. Edited by W. Bonfield, London, Sept. 10-11, (1991).

  1. “Bonding of Soft Tissues to Bioglass®”, J. Wilson and D. Noletti in Handbook of Bioactive Ceramics Vol. 1: bioactive Galsses and Glass-Ceramics, Yamamuro, L.L. Hench and J. Wilson, eds., CRC Press, Boca Raton, FL (1990).

  1. “Review of Bioactive Materials for Otologic and Maxillofacial Applications”; G. E. Merwin, in Handbook of Bioactive Ceramics, Vol I. Edited by T. Yamamuro, L. L. Hench and J. Wilson. CRC Press, Boca Raton, FL, (1990), pp. 323-328.

  1. “Bioactive Materials for Periodontal Treatment: A Comparative Study,” J. Wilson, S. Low, A. Fetner and L. L. Hench in Biomaterials and Clinical Applications, Pizzoferrato, P. G. Marchetti, A. Ravaglioli and A.J.C. Lee, eds., Elsevier Science Publishers, Amsterdam, (1987), 223-228.

  1. “Early Clinical Trials of 45S5 Bioglass® for Endosseous Ridge Maintenance with a New Endosseous Implant Material”, M.B. Hall, H.R. Stanley, C.King, F. Colaizzi, D. Spilman and L.L. Hench, Prosthetic Dentistry, 58 [5] (1987), 607-613.

  1. “Residual Alveolar Ridge Maintenance With a New Endosseous Implant Material”, H.R. Stanley, M.B. Hall, F. Colaizzi and A.E. Clark, Jr. in Maxillofacial Prosthetics, Dental Implants, Adisman, and R.P. Desjardins, eds. J. Prosthetic Dentistry 58 [5] (1987).

  1. “Bioglass® middle ear prosthesis: preliminary report”, GE Merwin, Ann Otol Rhinol Laryngol, 95; 1 Pt 1:78-82 January-February (1986).

  1. “Facial Bone Augmentation Using Bioglass® in Dogs”, J. Wilson, G. Merwin,L. Rogers, D.Spilman and R. Martin, in Surgical Research Recent Development, Proc. 1st Annual Scientific Session of Acad. Of Surgical Res., W. Hall, ed. Pergamon Press, (1985), 66-70

  1. Histopathological Evaluation of Interaction between Tympanic Membrane and Implant Materials”, June Wilson, J.S.Atkins, G.E.Merwin and L.L.Hench. Soc. For Biomat. Vol.8 195, 1985
  2. “Tissue Response to Surface Active Material”, J. Wilson and L. L. Hench, in The Dental Implant, R.V. McKinney Jr and J.E. Lemons eds., PSG Publishing Co. (1985) 181-196.

  1. “Bioglass Implants for Otology,” L. L. Hench, June Wilson and G. Merwin in Biomaterials in Otology, J. Grote, ed., Martinus Nijhoff Publishers, The Hague-Boston-London, 1983.

  1. “Comparison of Ossicular Replacement Materials in a Mouse Ear Model,” Gerald E. Merwin, James S. Atkins, June Wilson, Larry L. Hench, Head Neck Surg., 90 (1982) 461-469.

  1. “The Implantation of Natural Tooth Form Bioglass® in Baboons – Long Term Results,” H. R. Stanley, L. L. Hench, C. G. Bennett, Jr., S. J. Chellemi, C. J. King, III, R. E. Going, N. J. Ingersoll, E. C. Ethridge, K. L. Kreutziger, L. Loeb, and A. E. Clark, Intern. Oral Implantology 2 (1981) 26-36.

  1. “Toxicology and Biocompatibility of Bioglasses®,” J. Wilson, G. H. Pigott, F. J. Schoen and L. L. Hench, Biomed. Maters. Res. 15 (1981) 805-817.

  1. “Implantation of Natural Tooth Form Bioglasses in Baboon”, H.R. Stanley et.al., J. Oral Implantology, 1:2 (1976)

  1. “The Implantation of Natural Tooth Form Bioglasses in Baboons,” H. R. Stanley, L. L. Hench, R. Going, C. Bennett, S. J. Chellemi, C. King, N. Ingersoll, E. Ethridge, and K. Kreutziger, Oral Surg., Oral Med., Oral Pathology 45[5] (1976) 339-356

  1. “Histo-Chemical Responses at a Biomaterials Interface,” L. L. Hench and H. A. Paschall, Biomed. Mats. Res., No. 5 (Part 1) (1974) 49-64.

  1. “Direct Chemical Bonding of Bioactive Glass-Ceramic Materials and Bone,” L. L. Hench and H. A. Paschall, Biomed. Mats. Res. Symp. No. 4 (1973) 25-42.